| Healthcare Professionals: Home > About SEPRAFILM > Clinical Benefits |
|
Clinical BenefitsSEPRAFILM® is proven to reduce post-operative adhesions and related complications. It has been studied in more than 4,000 patients and in 20 published clinical reports.1 Reduction in Reoperative Adhesive Small Bowel ObstructionIn a prospective, randomized, controlled, blinded, multicenter study of patients receiving SEPRAFILM during intestinal resection, SEPRAFILM reduced reoperation required for adhesive SBO by 47% relative to untreated controls.2 Reduction in Reoperative ComplexityIn a series of prospective clinical studies in which SEPRAFILM was placed at the initial procedure, SEPRAFILM reduced adhesions observed at subsequent surgery, resulting in:
Reduction in Adhesions and Complexity at Repeat C-SectionIn a study of patients receiving SEPRAFILM at primary C-section, SEPRAFILM significantly reduced adhesions, resulting in decreased procedure and delivery times at repeat C-section.4 |
|
